A Single Patient IND for PD-0325901
A Phase I Single Patient IND for PD-0325901
1 other identifier
expanded_access
N/A
1 country
1
Brief Summary
The purpose of this study is to provide access for a single patient to PD-0325901 who was previously enrolled in a phase I clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 12, 2014
CompletedFirst Posted
Study publicly available on registry
November 21, 2014
CompletedNovember 26, 2014
November 1, 2014
1 month
May 12, 2014
November 24, 2014
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Prior treatment with PD-0325901 with ongoing response
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sharp HealthCarelead
Study Sites (1)
Sharp Healthcare
San Diego, California, 92123, United States
MeSH Terms
Interventions
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2014
First Posted
November 21, 2014
Study Start
June 1, 2013
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
November 26, 2014
Record last verified: 2014-11